Integer Holdings Corporation SEC filings document the disclosures of a NYSE-listed medical device CDMO with common stock trading under ITGR. Recent 8-K reports furnish quarterly and annual operating results, earnings-call materials, Regulation FD updates, capital-allocation actions, and material corporate events tied to the company’s medical device manufacturing business.
The filing record also covers governance and ownership matters, including definitive proxy materials, board composition, executive and director changes, committee assignments, compensation disclosures, shareholder meeting items, and cooperation-agreement terms with an investor group. These documents also disclose capital structure items such as common-stock registration details and share repurchase authorization.
Integer Holdings Corp (ITGR) reported an insider purchase by director Cheryl C. Capps. On 11/06/2025, she bought 1,600 shares of common stock at $66.7 per share. Following the transaction, she beneficially owns 11,702 shares, held directly. The filing indicates it was submitted by one reporting person.
Integer Holdings Corporation announced a share repurchase program authorizing the Company to buy back up to $200,000,000 of its common stock. The board approved the program on November 3, 2025, with no expiration date, allowing repurchases to occur over time at management’s discretion.
Repurchases may be made on the open market, in privately negotiated transactions, or through trading plans or other arrangements. The program does not obligate the Company to repurchase any specific amount, and it can be suspended or terminated.
Integer Holdings (ITGR) reported an insider purchase by its President & CEO and Director, Payman Khales. On 10/30/2025, he bought 3,127 shares of common stock at a weighted average price of $64.94, with trade prices ranging from $64.7805 to $64.94. Following the transaction, he directly beneficially owns 22,865 shares.
Integer Holdings Corp (ITGR) filed a Form 4 reporting an equity award to its President & CEO, Payman Khales. On 10/24/2025, the reporting person was granted 7,543 restricted stock units (RSUs) under Transaction Code A.
The RSUs convert into common stock on a one-for-one basis and will vest in three equal annual installments beginning 10/24/2026. The filing lists the price as $0 and the ownership form as Direct (D).
Integer Holdings Corporation appointed Payman Khales to its Board and as President and Chief Executive Officer, effective October 24, 2025. He will serve on the Technology Strategy Committee, with his director term running until the next annual meeting. Joseph W. Dziedzic, the outgoing CEO and director, will serve as Special Advisor through March 31, 2026 to support the transition.
The company entered into a new Employment Agreement with Mr. Khales on October 23, 2025, replacing his 2018 offer and change‑of‑control agreements. For certain terminations not tied to a change in control, pro‑rated vesting applies to performance awards outstanding at least one year and to time‑based awards granted on or after October 24, 2025. For qualifying terminations around a change in control—defined as from 60 days before to 24 months after—performance awards vest at the full opportunity as determined by the Compensation and Organization Committee, and time‑based awards vest in full. Payments may be reduced or paid in full based on the approach that yields the best after‑tax result. Mr. Khales will not receive additional compensation for Board service. A press release was furnished as Exhibit 99.1.
Integer Holdings (ITGR) filed a 10‑Q/A (Amendment No. 1) for the quarter ended September 26, 2025 to add context to MD&A. The amendment incorporates narrative from the October 23, 2025 earnings call about sales outlook and new product adoption expected to affect the next three fiscal quarters. No changes were made to the financial statements.
For Q3 2025, sales were $467.7 million and income from continuing operations was $39.7 million ($1.11 diluted EPS). Year‑to‑date, sales were $1.382 billion with $54.2 million of income from continuing operations ($1.52 diluted EPS). Cardio & Vascular sales rose 15% in Q3, aided by contributions from the Precision and VSi acquisitions.
Management updated its sales outlook to reflect lower‑than‑anticipated demand from select emerging customers and expects 2026 declines in three new products (two electrophysiology, one neuromodulation). In March 2025, the company issued $1.0 billion of 1.875% 2030 convertible notes (net $976.1 million), used $71.0 million for capped calls, and exchanged $383.7 million of 2028 notes for $384.4 million cash and 1,553,806 shares, recording $46.7 million inducement expense. As of October 17, 2025, shares outstanding were 35,038,426.
Integer Holdings Corporation reported third-quarter 2025 results. Sales were $467.7 million, up from $431.4 million a year ago. Operating income was $56.4 million versus $58.0 million. Net income rose to $39.7 million from $35.4 million, and diluted EPS was $1.11 compared with $0.99.
For the first nine months of 2025, sales reached $1.38 billion versus $1.27 billion. Net income was $54.2 million, down from $87.2 million, reflecting higher non-operating items, including a $46.7 million induced conversion expense recorded in other loss, net. Cash from operations was $140.7 million while investing used $235.3 million and financing provided $105.3 million.
Integer issued $1.0 billion of 2030 Convertible Notes at 1.875% (initial conversion price about $150.96) and exchanged $383.7 million of its 2028 notes for $384.4 million in cash plus 1,553,806 shares. It also purchased $71.0 million of capped calls. Cash was $58.9 million, long‑term debt $1.19 billion, and equity $1.75 billion. Q3 sales included $14.9 million from 2025 acquisitions (Precision Coating and VSi), and year‑to‑date contribution was $42.1 million. Shares outstanding as of October 17, 2025 were 35,038,426.
Integer Holdings Corporation furnished an 8‑K announcing its results for the third quarter ended September 26, 2025. The company issued a press release and updated its earnings conference call slide presentation, which will be referenced during the call and made available on its website.
The materials are furnished under Items 2.02 and 7.01, not filed, with the press release included as Exhibit 99.1.
On 24 July 2025, Integer Holdings Corporation (NYSE: ITGR) filed a Form 8-K to furnish, rather than file, information under Items 2.02 and 7.01.
- Item 2.02 — Results of Operations and Financial Condition: the company issued a press release announcing financial results for the quarter ended 27 June 2025, attached as Exhibit 99.1.
- Item 7.01 — Regulation FD Disclosure: an updated earnings-call slide deck will be available in the Investor Relations section of its website and referenced during the call.
The filing does not contain any quantitative results, guidance, or other financial metrics. All information is expressly furnished and is therefore not subject to Section 18 liability, nor is it incorporated by reference into Securities Act filings unless specifically stated.